TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    Investing

    3 Reasons the Canadian Economy Could Decline in 2018

    Dollarama Inc. (TSX:DOL) and other retailers are going to be severely impacted by rising minimum wages in 2018.

    Read more »

    Tech Stocks

    3 Turnaround Candidates for 2018 You Should Consider Now

    Beleaguered companies such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and others could stand to finally see a turnaround in 2018.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc Jumped 35% Last Month: Is the Stock Taking off?

    Valeant Pharmaceuticals Intl Inc (TSX:VRX)(NYSE:VRX) has seen its stock soar recently and investors may want to take a second look…

    Read more »

    The Motley Fool
    Investing

    Why Valeant Pharmaceuticals Intl Inc. Surged Almost 10% Today

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is clearly making progress under its new CEO, but there are still many hurdles to…

    Read more »

    time is money compounding
    Investing

    Valeant Pharmaceuticals Intl Inc. Is up! Time to Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to pay down and refinance its debt to more favourable terms. As the business…

    Read more »

    Investing

    After Reaching Another 52-Week High, Valeant Pharmaceuticals Intl Inc. Should Still Be Avoided at All Costs!

    Shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) should still be avoided at all costs.

    Read more »

    Investing

    2 Fallen Stars That Will Fly High Again

    BlackBerry Ltd. (TSX:BB)(NYSE:BB) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are two businesses that have reinvented themselves. Here's why you should…

    Read more »

    Investing

    4 Non-Cannabis Stocks That Have Grown 25% in the Past 3 Months

    Bombardier, Inc. (TSX:BBD.B) and these three other stocks could provide investors with excellent growth opportunities.

    Read more »

    The Motley Fool
    Investing

    Queue the 2018 Rebound for Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be slated to enjoy a huge 2018. Here's why investors may want to back…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals International Inc. Is Trading at 52-Week Highs: Should You Buy or Sell?

    Valeant Pharmaceutical International Inc. (TSX:VRX)(NYSE:VRX) is still in early stages of a comeback, with many hurdles to overcome.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.’s Recent Debt Offering a Genius Move

    By refinancing $1.5 billion of debt due in 2020, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) CEO Joe Papa has continued to impress…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Surges ~12% in a Day: Why the Stock Could Easily Double in 2018

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) surged along with the biotech and pharma industry. Here's why investors should expect more big…

    Read more »